{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:09:44Z","timestamp":1791288584805,"version":"4.3.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2011,2,15]],"date-time":"2011-02-15T00:00:00Z","timestamp":1297728000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell Res"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1038\/cr.2011.21","type":"journal-article","created":{"date-parts":[[2011,2,15]],"date-time":"2011-02-15T17:53:56Z","timestamp":1297792436000},"page":"1102-1115","source":"Crossref","is-referenced-by-count":94,"title":["Osteoclast activity modulates B-cell development in the bone marrow"],"prefix":"10.1038","volume":"21","author":[{"given":"Anna","family":"Mansour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne","family":"Anginot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane J C","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudine","family":"Schiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges F","family":"Carle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelilah","family":"Wakkach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudine","family":"Blin-Wakkach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,2,15]]},"reference":[{"key":"BFcr201121_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1146\/annurev.immunol.24.021605.090646","volume":"24","author":"MC Walsh","year":"2006","unstructured":"Walsh MC, Kim N, Kadono Y, et al. Osteoimmunology: interplay between the immune system and bone metabolism. Annu Rev Immunol 2006; 24:33\u201363.","journal-title":"Annu Rev Immunol"},{"key":"BFcr201121_CR2","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/nature02041","volume":"425","author":"J Zhang","year":"2003","unstructured":"Zhang J, Niu C, Ye L, et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003; 425:836\u2013841.","journal-title":"Nature"},{"key":"BFcr201121_CR3","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/nature02040","volume":"425","author":"LM Calvi","year":"2003","unstructured":"Calvi LM, Adams GB, Weibrecht KW, et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003; 425:841\u2013846.","journal-title":"Nature"},{"key":"BFcr201121_CR4","doi-asserted-by":"publisher","first-page":"3258","DOI":"10.1182\/blood-2003-11-4011","volume":"103","author":"D Visnjic","year":"2004","unstructured":"Visnjic D, Kalajzic Z, Rowe DW, et al. Hematopoiesis is severely altered in mice with an induced osteoblast deficiency. Blood 2004; 103:3258\u20133264.","journal-title":"Blood"},{"key":"BFcr201121_CR5","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.immuni.2004.05.001","volume":"20","author":"K Tokoyoda","year":"2004","unstructured":"Tokoyoda K, Egawa T, Sugiyama T, Choi BI, Nagasawa T . Cellular niches controlling B lymphocyte behavior within bone marrow during development. Immunity 2004; 20:707\u2013718.","journal-title":"Immunity"},{"key":"BFcr201121_CR6","doi-asserted-by":"publisher","first-page":"16976","DOI":"10.1073\/pnas.0802898105","volume":"105","author":"JY Wu","year":"2008","unstructured":"Wu JY, Purton LE, Rodda SJ, et al. Osteoblastic regulation of B lymphopoiesis is mediated by Gs{alpha}-dependent signaling pathways. Proc Natl Acad Sci USA 2008; 105:16976\u201316981.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcr201121_CR7","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1084\/jem.173.5.1213","volume":"173","author":"RR Hardy","year":"1991","unstructured":"Hardy RR, Carmack CE, Shinton SA, Kemp JD, Hayakawa K . Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J Exp Med 1991; 173:1213\u20131225.","journal-title":"J Exp Med"},{"key":"BFcr201121_CR8","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1146\/annurev.immunol.19.1.595","volume":"19","author":"RR Hardy","year":"2001","unstructured":"Hardy RR, Hayakawa K . B cell development pathways. Annu Rev Immunol 2001; 19:595\u2013621.","journal-title":"Annu Rev Immunol"},{"key":"BFcr201121_CR9","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.1182\/blood-2006-08-041384","volume":"109","author":"J Zhu","year":"2007","unstructured":"Zhu J, Garrett R, Jung Y, et al. Osteoblasts support B-lymphocyte commitment and differentiation from hematopoietic stem cells. Blood 2007; 109:3706\u20133712.","journal-title":"Blood"},{"key":"BFcr201121_CR10","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/382635a0","volume":"382","author":"T Nagasawa","year":"1996","unstructured":"Nagasawa T, Hirota S, Tachibana K, et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF\/SDF-1. Nature 1996; 382:635\u2013638.","journal-title":"Nature"},{"key":"BFcr201121_CR11","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S1074-7613(00)80046-1","volume":"10","author":"Q Ma","year":"1999","unstructured":"Ma Q, Jones D, Springer TA . The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity 1999; 10:463\u2013471.","journal-title":"Immunity"},{"key":"BFcr201121_CR12","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S1074-7613(01)00185-6","volume":"15","author":"T Egawa","year":"2001","unstructured":"Egawa T, Kawabata K, Kawamoto H, et al. The earliest stages of B cell development require a chemokine stromal cell-derived factor\/pre-B cell growth-stimulating factor. Immunity 2001; 15:323\u2013334.","journal-title":"Immunity"},{"key":"BFcr201121_CR13","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1084\/jem.181.4.1519","volume":"181","author":"U von Freeden-Jeffry","year":"1995","unstructured":"von Freeden-Jeffry U, Vieira P, Lucian LA, et al. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med 1995; 181:1519\u20131526.","journal-title":"J Exp Med"},{"key":"BFcr201121_CR14","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1101\/gad.13.18.2412","volume":"13","author":"WC Dougall","year":"1999","unstructured":"Dougall WC, Glaccum M, Charrier K, et al. RANK is essential for osteoclast and lymph node development. Genes Dev 1999; 13:2412\u20132424.","journal-title":"Genes Dev"},{"key":"BFcr201121_CR15","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.1101\/gad.11.24.3482","volume":"11","author":"G Franzoso","year":"1997","unstructured":"Franzoso G, Carlson L, Xing L, et al. Requirement for NF-kappaB in osteoclast and B-cell development. Genes Dev 1997; 11:3482\u20133496.","journal-title":"Genes Dev"},{"key":"BFcr201121_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/16852","volume":"397","author":"YY Kong","year":"1999","unstructured":"Kong YY, Yoshida H, Sarosi I, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999; 397:315\u2013323.","journal-title":"Nature"},{"key":"BFcr201121_CR17","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1046\/j.1365-2443.1999.00265.x","volume":"4","author":"A Naito","year":"1999","unstructured":"Naito A, Azuma S, Tanaka S, et al. Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells 1999; 4:353\u2013362.","journal-title":"Genes Cells"},{"key":"BFcr201121_CR18","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1182\/blood.V95.11.3363","volume":"95","author":"H Tagaya","year":"2000","unstructured":"Tagaya H, Kunisada T, Yamazaki H, et al. Intramedullary and extramedullary B lymphopoiesis in osteopetrotic mice. Blood 2000; 95:3363\u20133370.","journal-title":"Blood"},{"key":"BFcr201121_CR19","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/345442a0","volume":"345","author":"H Yoshida","year":"1990","unstructured":"Yoshida H, Hayashi S, Kunisada T, et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 1990; 345:442\u2013444.","journal-title":"Nature"},{"key":"BFcr201121_CR20","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1038\/sj.leu.2403449","volume":"18","author":"C Blin-Wakkach","year":"2004","unstructured":"Blin-Wakkach C, Wakkach A, Sexton PM, Rochet N, Carle GF . Hematological defects in the oc\/oc mouse, a model of infantile malignant osteopetrosis. Leukemia 2004; 18:1505\u20131511.","journal-title":"Leukemia"},{"key":"BFcr201121_CR21","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S8756-3282(99)00278-1","volume":"26","author":"JC Scimeca","year":"2000","unstructured":"Scimeca JC, Franchi A, Trojani C, et al. The gene encoding the mouse homologue of the human osteoclast-specific 116-kDa V-ATPase subunit bears a deletion in osteosclerotic (oc\/oc) mutants. Bone 2000; 26:207\u2013213.","journal-title":"Bone"},{"key":"BFcr201121_CR22","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1359\/JBMR.040318","volume":"7","author":"C Blin-Wakkach","year":"2004","unstructured":"Blin-Wakkach C, Wakkach A, Rochet N, Carle GF . Characterization of a novel bipotent hematopoietic progenitor population in normal and osteopetrotic mouse. J Bone Miner Res 2004; 7:1137\u20131143.","journal-title":"J Bone Miner Res"},{"key":"BFcr201121_CR23","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.exphem.2006.04.003","volume":"34","author":"C Blin-Wakkach","year":"2006","unstructured":"Blin-Wakkach C, Wakkach A, Quincey D, Carle GF . Interleukin-7 partially rescues B-lymphopoiesis in osteopetrotic oc\/oc mice through the engagement of B220(+)CD11b(+) progenitors. Exp Hematol 2006; 34:851\u2013859.","journal-title":"Exp Hematol"},{"key":"BFcr201121_CR24","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","volume":"19","author":"RG Russell","year":"2008","unstructured":"Russell RG, Watts NB, Ebetino FH, Rogers MJ . Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int 2008; 19:733\u2013759.","journal-title":"Osteoporos Int"},{"key":"BFcr201121_CR25","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s00223-002-2015-4","volume":"72","author":"SB Hornby","year":"2003","unstructured":"Hornby SB, Evans GP, Hornby SL, et al. Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats. Calcif Tissue Int 2003; 72:519\u2013527.","journal-title":"Calcif Tissue Int"},{"key":"BFcr201121_CR26","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1002\/art.20384","volume":"50","author":"P Herrak","year":"2004","unstructured":"Herrak P, Gortz B, Hayer S, et al. Zoledronic acid protects against local and systemic bone loss in tumor necrosis factor-mediated arthritis. Arthritis Rheum 2004; 50:2327\u20132337.","journal-title":"Arthritis Rheum"},{"key":"BFcr201121_CR27","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/cncr.21104","volume":"104","author":"A Corso","year":"2005","unstructured":"Corso A, Ferretti E, Lunghi M, et al. Zoledronic acid down-regulates adhesion molecules of bone marrow stromal cells in multiple myeloma. A possible mechanism for its antitumor effect. Cancer 2005; 104:118\u2013125.","journal-title":"Cancer"},{"key":"BFcr201121_CR28","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/ijc.24758","volume":"126","author":"A Guenther","year":"2010","unstructured":"Guenther A, Gordon S, Tiemann M, et al. The bisphosphonate zoledronic acid has anti-myeloma activity in vivo by inhibition of protein prenylation. Int J Cancer 2010; 126:239\u2013246.","journal-title":"Int J Cancer"},{"key":"BFcr201121_CR29","doi-asserted-by":"publisher","first-page":"5074","DOI":"10.1182\/blood-2008-01-132787","volume":"112","author":"A Wakkach","year":"2008","unstructured":"Wakkach A, Mansour A, Dacquin R, et al. Bone marrow microenvironment controls the in vivo differentiation of murine dendritic cells into osteoclasts. Blood 2008; 112:5074\u20135083.","journal-title":"Blood"},{"key":"BFcr201121_CR30","doi-asserted-by":"publisher","first-page":"14629","DOI":"10.1073\/pnas.0507637102","volume":"102","author":"A Frattini","year":"2005","unstructured":"Frattini A, Blair HC, Sacco MG, et al. Rescue of ATPa3-deficient murine malignant osteopetrosis by hematopoietic stem cell transplantation in utero. Proc Natl Acad Sci USA 2005; 102:14629\u201314634.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcr201121_CR31","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.exphem.2005.11.010","volume":"34","author":"M Johansson","year":"2006","unstructured":"Johansson M, Jansson L, Ehinger M, et al. Neonatal hematopoietic stem cell transplantation cures oc\/oc mice from osteopetrosis. Exp Hematol 2006; 34:242\u2013249.","journal-title":"Exp Hematol"},{"key":"BFcr201121_CR32","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1359\/jbmr.080511","volume":"23","author":"MP Whyte","year":"2008","unstructured":"Whyte MP, McAlister WH, Novack DV, et al. Bisphosphonate-induced osteopetrosis: novel bone modeling defects, metaphyseal osteopenia, and osteosclerosis fractures after drug exposure ceases. J Bone Miner Res 2008; 23:1698\u20131707.","journal-title":"J Bone Miner Res"},{"key":"BFcr201121_CR33","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1101\/gad.1836009","volume":"23","author":"MA Inlay","year":"2009","unstructured":"Inlay MA, Bhattacharya D, Sahoo D, et al. Ly6d marks the earliest stage of B-cell specification and identifies the branchpoint between B-cell and T-cell development. Genes Dev 2009; 23:2376\u20132381.","journal-title":"Genes Dev"},{"key":"BFcr201121_CR34","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1359\/jbmr.070109","volume":"22","author":"MA Karsdal","year":"2007","unstructured":"Karsdal MA, Martin TJ, Bollerslev J, Christiansen C, Henriksen K . Are nonresorbing osteoclasts sources of bone anabolic activity? J Bone Miner Res 2007; 22:487\u2013494.","journal-title":"J Bone Miner Res"},{"key":"BFcr201121_CR35","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.abb.2008.03.027","volume":"473","author":"K Matsuo","year":"2008","unstructured":"Matsuo K, Irie N . Osteoclast\u2013osteoblast communication. Arch Biochem Biophys 2008; 473:201\u2013209.","journal-title":"Arch Biochem Biophys"},{"key":"BFcr201121_CR36","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S0092-8674(00)80257-3","volume":"89","author":"P Ducy","year":"1997","unstructured":"Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G . Osf2\/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997; 89:747\u2013754.","journal-title":"Cell"},{"key":"BFcr201121_CR37","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1359\/jbmr.1999.14.5.722","volume":"14","author":"E van Beek","year":"1999","unstructured":"van Beek E, Lowik C, Van der Pluijm G, Papapoulos S . The role of geranylgeranylation in bone resorption and its suppression by bisphosphonates in fetal bone explants in vitro: a clue to the mechanism of action of nitrogen-containing bisphosphonates. J Bone Miner Res 1999; 14:722\u2013729.","journal-title":"J Bone Miner Res"},{"key":"BFcr201121_CR38","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1359\/jbmr.2000.15.8.1467","volume":"15","author":"FP Coxon","year":"2000","unstructured":"Coxon FP, Helfrich MH, van 't Hof RJ, et al. Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298. J Bone Miner Res 2000; 15:1467\u20131476.","journal-title":"J Bone Miner Res"},{"key":"BFcr201121_CR39","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.2174\/1381612033453640","volume":"9","author":"MJ Rogers","year":"2003","unstructured":"Rogers MJ . New insights into the molecular mechanisms of action of bisphosphonates. Curr Pharm Des 2003; 9:2643\u20132658.","journal-title":"Curr Pharm Des"},{"key":"BFcr201121_CR40","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1196\/annals.1402.089","volume":"1117","author":"RG Russell","year":"2007","unstructured":"Russell RG, Xia Z, Dunford JE, et al. Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy. Ann N Y Acad Sci 2007; 1117:209\u2013257.","journal-title":"Ann N Y Acad Sci"},{"key":"BFcr201121_CR41","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1002\/art.20382","volume":"50","author":"NA Sims","year":"2004","unstructured":"Sims NA, Green JR, Glatt M, et al. Targeting osteoclasts with zoledronic acid prevents bone destruction in collagen-induced arthritis. Arthritis Rheum 2004; 50:2338\u20132346.","journal-title":"Arthritis Rheum"},{"key":"BFcr201121_CR42","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s002239900519","volume":"63","author":"S Colucci","year":"1998","unstructured":"Colucci S, Minielli V, Zambonin G, et al. Alendronate reduces adhesion of human osteoclast-like cells to bone and bone protein-coated surfaces. Calcif Tissue Int 1998; 63:230\u2013235.","journal-title":"Calcif Tissue Int"},{"key":"BFcr201121_CR43","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/aja.1001720204","volume":"172","author":"MF Seifert","year":"1985","unstructured":"Seifert MF, Marks SC, Jr . Morphological evidence of reduced bone resorption in the osteosclerotic (oc) mouse. Am J Anat 1985; 172:141\u2013153.","journal-title":"Am J Anat"},{"key":"BFcr201121_CR44","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1084\/jem.180.5.1955","volume":"180","author":"JJ Peschon","year":"1994","unstructured":"Peschon JJ, Morrissey PJ, Grabstein KH, et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med 1994; 180:1955\u20131960.","journal-title":"J Exp Med"},{"key":"BFcr201121_CR45","doi-asserted-by":"publisher","first-page":"5663","DOI":"10.1073\/pnas.96.10.5663","volume":"96","author":"K Kawabata","year":"1999","unstructured":"Kawabata K, Ujikawa M, Egawa T, et al. A cell-autonomous requirement for CXCR4 in long-term lymphoid and myeloid reconstitution. Proc Natl Acad Sci USA 1999; 96:5663\u20135667.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcr201121_CR46","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1210\/jc.2004-0509","volume":"90","author":"L Tauchmanova","year":"2005","unstructured":"Tauchmanova L, Ricci P, Serio B, et al. Short-term zoledronic acid treatment increases bone mineral density and marrow clonogenic fibroblast progenitors after allogeneic stem cell transplantation. J Clin Endocrinol Metab 2005; 90:627\u2013634.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFcr201121_CR47","doi-asserted-by":"publisher","first-page":"6941","DOI":"10.1016\/j.biomaterials.2005.04.059","volume":"26","author":"F von Knoch","year":"2005","unstructured":"von Knoch F, Jaquiery C, Kowalsky M, et al. Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells. Biomaterials 2005; 26:6941\u20136949.","journal-title":"Biomaterials"},{"key":"BFcr201121_CR48","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1359\/jbmr.070906","volume":"23","author":"RR Recker","year":"2008","unstructured":"Recker RR, Delmas PD, Halse J, et al. Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure. J Bone Miner Res 2008; 23:6\u201316.","journal-title":"J Bone Miner Res"},{"key":"BFcr201121_CR49","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/jcb.21983","volume":"106","author":"IR Orriss","year":"2009","unstructured":"Orriss IR, Key ML, Colston KW, Arnett TR . Inhibition of osteoblast function in vitro by aminobisphosphonates. J Cell Biochem 2009; 106:109\u2013118.","journal-title":"J Cell Biochem"},{"key":"BFcr201121_CR50","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.bbrc.2005.09.198","volume":"338","author":"A Schindeler","year":"2005","unstructured":"Schindeler A, Little DG . Osteoclasts but not osteoblasts are affected by a calcified surface treated with zoledronic acid in vitro. Biochem Biophys Res Commun 2005; 338:710\u2013716.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFcr201121_CR51","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1084\/jem.20071294","volume":"205","author":"L Malaval","year":"2008","unstructured":"Malaval L, Wade-Gu\u00e9ye NM, Boudiffa M, et al. Bone sialoprotein plays a functional role in bone formation and osteoclastogenesis. J Exp Med 2008; 205:1145\u20131153.","journal-title":"J Exp Med"},{"key":"BFcr201121_CR52","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001; 25:402\u2013408.","journal-title":"Methods"},{"key":"BFcr201121_CR53","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1359\/jbmr.1997.12.9.1335","volume":"12","author":"SA Kuznetsov","year":"1997","unstructured":"Kuznetsov SA, Krebsbach PH, Satomura K, et al. Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J Bone Miner Res 1997; 12:1335\u20131347.","journal-title":"J Bone Miner Res"}],"container-title":["Cell Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/cr201121.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cr201121","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cr201121.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:30:01Z","timestamp":1684416601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cr201121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,15]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["BFcr201121"],"URL":"https:\/\/doi.org\/10.1038\/cr.2011.21","relation":{},"ISSN":["1001-0602","1748-7838"],"issn-type":[{"value":"1001-0602","type":"print"},{"value":"1748-7838","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,15]]}}}